Kiniksa Pharmaceuticals to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
September 09 2020 - 4:01PM
Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that
it will present at the Morgan Stanley 18th Annual Global
Healthcare Conference on Wednesday, September 16th, 2020 at 2:00
p.m. Eastern Time.
A live webcast of Kiniksa’s presentation will be
accessible through the Investors & Media section of the
company’s website at www.kiniksa.com. A replay of the webcast will
be available on Kiniksa’s website for 14 days following the
conference.
About KiniksaKiniksa is a
biopharmaceutical company focused on discovering, acquiring,
developing and commercializing therapeutic medicines for patients
suffering from debilitating diseases with significant unmet medical
need. Kiniksa’s clinical-stage product candidates, rilonacept,
mavrilimumab, vixarelimab and KPL-404, are based on strong biologic
rationale or validated mechanisms, target underserved conditions
and offer the potential for differentiation. These pipeline assets
are designed to modulate immunological pathways that are implicated
across a spectrum of diseases. For more information, please
visit www.kiniksa.com.
Every Second Counts!™
Kiniksa Investor and Media ContactMark Ragosa(781)
430-8289mragosa@kiniksa.com
Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Sep 2023 to Sep 2024